Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2010 1
2012 1
2013 2
2014 6
2015 4
2016 4
2017 11
2018 9
2019 9
2020 8
2021 19
2022 23
2023 22
2024 25
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease.
COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators; Bhatt SP, Abadi E, Anzueto A, Bodduluri S, Casaburi R, Castaldi PJ, Cho MH, Comellas AP, Conrad DJ, Curtis JL, Dass C, DeMeo DL, Dransfield MT, San José Estépar R, Flenaugh EL, Foreman MG, Fortis S, Gupta A, Han MK, Hanania NA, Hersh CP, Hokanson JE, Humphries SM, Kirby M, Kunisaki KM, Li PZ, Lynch DA, MacIntyre NR, Make BJ, Mannino DM, Martinez FJ, McEvoy CE, Miller BE, Moll M, Nakhmani A, Newell JD Jr, Pratte KA, Regan EA, Reinhardt JM, Rennard SI, Rossiter HB, Strand MJ, Suri R, Wan ES, Wendt CH, Westney GE, Wilson CG, Wise RA, Young KA, Tan WC, Silverman EK, Crapo JD. COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators, et al. Among authors: fortis s. JAMA. 2025 Jun 24;333(24):2164-2175. doi: 10.1001/jama.2025.7358. JAMA. 2025. PMID: 40382791
FEV1/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.
Bhatt SP, Nakhmani A, Fortis S, Strand MJ, Silverman EK, Sciurba FC, Bodduluri S. Bhatt SP, et al. Among authors: fortis s. Am J Respir Crit Care Med. 2023 Sep 15;208(6):676-684. doi: 10.1164/rccm.202303-0450OC. Am J Respir Crit Care Med. 2023. PMID: 37339502 Free PMC article.
Combination Immunotherapy in Prostate Cancer.
Baxevanis CN, Goulielmaki M, Gritzapis AD, Fortis SP. Baxevanis CN, et al. Among authors: fortis sp. Cancers (Basel). 2022 Dec 8;14(24):6040. doi: 10.3390/cancers14246040. Cancers (Basel). 2022. PMID: 36551526 Free PMC article.
Response.
Fortis S, Sarrazin MV, Beck BF, Panos RJ, Reisinger HS. Fortis S, et al. Chest. 2018 Oct;154(4):988-989. doi: 10.1016/j.chest.2018.07.035. Chest. 2018. PMID: 30290937 No abstract available.
The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
Sofopoulos M, Fortis SP, Vaxevanis CK, Sotiriadou NN, Arnogiannaki N, Ardavanis A, Vlachodimitropoulos D, Perez SA, Baxevanis CN. Sofopoulos M, et al. Among authors: fortis sp. Cancer Immunol Immunother. 2019 Nov;68(11):1733-1745. doi: 10.1007/s00262-019-02407-8. Epub 2019 Oct 9. Cancer Immunol Immunother. 2019. PMID: 31598757 Free PMC article.
Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
Chaudhary MFA, Hoffman EA, Guo J, Comellas AP, Newell JD Jr, Nagpal P, Fortis S, Christensen GE, Gerard SE, Pan Y, Wang D, Abtin F, Barjaktarevic IZ, Barr RG, Bhatt SP, Bodduluri S, Cooper CB, Gravens-Mueller L, Han MK, Kazerooni EA, Martinez FJ, Menchaca MG, Ortega VE, Iii RP, Schroeder JD, Woodruff PG, Reinhardt JM. Chaudhary MFA, et al. Among authors: fortis s. Lancet Digit Health. 2023 Feb;5(2):e83-e92. doi: 10.1016/S2589-7500(22)00232-1. Lancet Digit Health. 2023. PMID: 36707189 Free PMC article.
141 results